Viatris (VTRS) Invested Capital (2018 - 2026)
Viatris (VTRS) recorded quarterly Invested Capital of $15.7 billion in Q1 2026, down 3.39% quarter-over-quarter from $16.2 billion in Q4 2025, and down 8.72% on a YoY basis from $17.1 billion in Q1 2025.
Viatris (VTRS) Invested Capital (2018 - 2026) Analysis & Trends
Viatris' Invested Capital history runs 9 years deep, the most recent figure standing at $15.7 billion for Q1 2026.
- In Q1 2026, Invested Capital fell 8.72% year-over-year to $15.7 billion; the TTM figure through Mar 2026 stood at $15.7 billion (down 8.72% YoY), while the FY2025 annual figure was $16.2 billion, down 19.05% from the prior year.
- Invested Capital was $15.7 billion for Q1 2026 at Viatris, down from $16.2 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $23.3 billion in Q4 2022 to a low of $15.7 billion in Q1 2026.
- Historically, Invested Capital has averaged $20.0 billion across 5 years, with a median of $21.2 billion in 2024.
- The sharpest annual moves came in 2022 and 2025: Invested Capital increased 9.49% in 2022, then declined 22.82% in 2025.
- A 5-year view of Invested Capital shows it stood at $23.3 billion in 2022, then decreased by 8.81% to $21.2 billion in 2023, then retreated by 5.71% to $20.0 billion in 2024, then declined by 19.05% to $16.2 billion in 2025, then dropped by 3.39% to $15.7 billion in 2026.
- The last three Invested Capital figures came in at $15.7 billion (Q1 2026), $16.2 billion (Q4 2025), and $16.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 3.41 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 373.23 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.79 Bn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 108.58 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 15.65 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.65 Bn |
| Dec 31, 2025 | 16.20 Bn |
| Sep 30, 2025 | 16.77 Bn |
| Jun 30, 2025 | 16.33 Bn |
| Mar 31, 2025 | 17.15 Bn |
| Dec 31, 2024 | 20.01 Bn |
| Sep 30, 2024 | 20.76 Bn |
| Jun 30, 2024 | 21.16 Bn |
| Mar 31, 2024 | 22.21 Bn |
| Dec 31, 2023 | 21.22 Bn |
| Sep 30, 2023 | 21.79 Bn |
| Jun 30, 2023 | 22.31 Bn |
| Mar 31, 2023 | 21.23 Bn |
| Dec 31, 2022 | 23.27 Bn |
| Sep 30, 2022 | 19.94 Bn |
| Jun 30, 2022 | 21.23 Bn |
| Mar 31, 2022 | 21.95 Bn |
| Dec 31, 2021 | 21.26 Bn |
| Sep 30, 2021 | 22.80 Bn |
| Jun 30, 2021 | 21.99 Bn |